These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 9334378)
1. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry. Princen K; Hatse S; Vermeire K; De Clercq E; Schols D Cytometry A; 2003 Jan; 51(1):35-45. PubMed ID: 12500303 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist. Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651 [TBL] [Abstract][Full Text] [Related]
4. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use. Schols D; Esté JA; Cabrera C; De Clercq E J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691 [TBL] [Abstract][Full Text] [Related]
5. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Schols D; Esté JA; Henson G; De Clercq E Antiviral Res; 1997 Aug; 35(3):147-56. PubMed ID: 9298754 [TBL] [Abstract][Full Text] [Related]
6. HIV co-receptors as targets for antiviral therapy. Schols D Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547 [TBL] [Abstract][Full Text] [Related]
7. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238 [TBL] [Abstract][Full Text] [Related]
8. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Fricker SP; Anastassov V; Cox J; Darkes MC; Grujic O; Idzan SR; Labrecque J; Lau G; Mosi RM; Nelson KL; Qin L; Santucci Z; Wong RS Biochem Pharmacol; 2006 Aug; 72(5):588-96. PubMed ID: 16815309 [TBL] [Abstract][Full Text] [Related]
10. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. Schols D; De Clercq E J Gen Virol; 1998 Sep; 79 ( Pt 9)():2203-5. PubMed ID: 9747729 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies. Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150 [TBL] [Abstract][Full Text] [Related]
12. Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist. Schols D Verh K Acad Geneeskd Belg; 1999; 61(4):551-64. PubMed ID: 10500476 [TBL] [Abstract][Full Text] [Related]
13. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367 [TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. Hatse S; Princen K; Bridger G; De Clercq E; Schols D FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670 [TBL] [Abstract][Full Text] [Related]
15. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance. Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684 [TBL] [Abstract][Full Text] [Related]
16. CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells. Zhang Y; Hatse S; De Clercq E; Schols D J Virol; 2000 Feb; 74(4):2011-6. PubMed ID: 10644374 [TBL] [Abstract][Full Text] [Related]
17. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Donzella GA; Schols D; Lin SW; Esté JA; Nagashima KA; Maddon PJ; Allaway GP; Sakmar TP; Henson G; De Clercq E; Moore JP Nat Med; 1998 Jan; 4(1):72-7. PubMed ID: 9427609 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. De Clercq E; Schols D Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685 [TBL] [Abstract][Full Text] [Related]
19. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280 [TBL] [Abstract][Full Text] [Related]
20. The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level. Princen K; Hatse S; Vermeire K; Bridger GJ; Skerlj RT; De Clercq E; Schols D AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1135-9. PubMed ID: 14709250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]